These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 22824293

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Synergistic antitumor efficacy against the EGFRvIII+HER2+ breast cancers by combining trastuzumab with anti-EGFRvIII antibody CH12.
    Xu W, Bi Y, Zhang J, Kong J, Jiang H, Tian M, Li K, Wang B, Chen C, Song F, Pan X, Shi B, Kong X, Gu J, Cai X, Li Z.
    Oncotarget; 2015 Nov 17; 6(36):38840-53. PubMed ID: 26474285
    [Abstract] [Full Text] [Related]

  • 44. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
    Lin L, Hutzen B, Li PK, Ball S, Zuo M, DeAngelis S, Foust E, Sobo M, Friedman L, Bhasin D, Cen L, Li C, Lin J.
    Neoplasia; 2010 Jan 17; 12(1):39-50. PubMed ID: 20072652
    [Abstract] [Full Text] [Related]

  • 45. A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine.
    Le Joncour V, Martins A, Puhka M, Isola J, Salmikangas M, Laakkonen P, Joensuu H, Barok M.
    Mol Cancer Ther; 2019 Oct 17; 18(10):1721-1730. PubMed ID: 31292166
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
    Ghattass K, El-Sitt S, Zibara K, Rayes S, Haddadin MJ, El-Sabban M, Gali-Muhtasib H.
    Mol Cancer; 2014 Jan 24; 13():12. PubMed ID: 24461075
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
    Duru N, Fan M, Candas D, Menaa C, Liu HC, Nantajit D, Wen Y, Xiao K, Eldridge A, Chromy BA, Li S, Spitz DR, Lam KS, Wicha MS, Li JJ.
    Clin Cancer Res; 2012 Dec 15; 18(24):6634-47. PubMed ID: 23091114
    [Abstract] [Full Text] [Related]

  • 50. Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase-3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic sarcoma U-2 OS cells.
    Wu CL, Huang AC, Yang JS, Liao CL, Lu HF, Chou ST, Ma CY, Hsia TC, Ko YC, Chung JG.
    J Orthop Res; 2011 Aug 15; 29(8):1199-209. PubMed ID: 21374707
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.
    Piechocki MP, Yoo GH, Dibbley SK, Lonardo F.
    Cancer Res; 2007 Jul 15; 67(14):6825-43. PubMed ID: 17638894
    [Abstract] [Full Text] [Related]

  • 53. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
    Huang W, Wu QD, Zhang M, Kong YL, Cao PR, Zheng W, Xu JH, Ye M.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):862-71. PubMed ID: 25449780
    [Abstract] [Full Text] [Related]

  • 54. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
    Yeh YT, Yeh H, Su SH, Lin JS, Lee KJ, Shyu HW, Chen ZF, Huang SY, Su SJ.
    Free Radic Biol Med; 2014 Sep 28; 74():1-13. PubMed ID: 24952138
    [Abstract] [Full Text] [Related]

  • 55. Phenethyl isothiocyanate upregulates death receptors 4 and 5 and inhibits proliferation in human cancer stem-like cells.
    Wang D, Upadhyaya B, Liu Y, Knudsen D, Dey M.
    BMC Cancer; 2014 Aug 15; 14():591. PubMed ID: 25127663
    [Abstract] [Full Text] [Related]

  • 56. Phenethyl isothiocyanate potentiates anti-tumour effect of doxorubicin through Akt-dependent pathway.
    Eisa NH, ElSherbiny NM, Shebl AM, Eissa LA, El-Shishtawy MM.
    Cell Biochem Funct; 2015 Dec 15; 33(8):541-51. PubMed ID: 26548747
    [Abstract] [Full Text] [Related]

  • 57. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.
    Stan SD, Hahm ER, Warin R, Singh SV.
    Cancer Res; 2008 Sep 15; 68(18):7661-9. PubMed ID: 18794155
    [Abstract] [Full Text] [Related]

  • 58. Grifola frondosa polysaccharides induce breast cancer cell apoptosis via the mitochondrial-dependent apoptotic pathway.
    Zhang Y, Sun D, Meng Q, Guo W, Chen Q, Zhang Y.
    Int J Mol Med; 2017 Oct 15; 40(4):1089-1095. PubMed ID: 28765878
    [Abstract] [Full Text] [Related]

  • 59. Annonacin induces cell cycle-dependent growth arrest and apoptosis in estrogen receptor-α-related pathways in MCF-7 cells.
    Ko YM, Wu TY, Wu YC, Chang FR, Guh JY, Chuang LY.
    J Ethnopharmacol; 2011 Oct 11; 137(3):1283-90. PubMed ID: 21840388
    [Abstract] [Full Text] [Related]

  • 60. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.
    Ray A, Nkhata KJ, Cleary MP.
    Int J Oncol; 2007 Jun 11; 30(6):1499-509. PubMed ID: 17487372
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.